✦ LIBER ✦

Current status of safinamide for the drug portfolio of Parkinson’s disease therapy

✍ Scribed by Müller, Thomas

Book ID: 121852482
Publisher: Expert Reviews
Year: 2013
Tongue: English
Weight: 245 KB
Volume: 13
Category: Article
ISSN: 1473-7175
DOI: 10.1586/14737175.2013.827488

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current status of gene therapy trials fo

Current status of gene therapy trials for Parkinson's disease

✍ Massimo Fiandaca; John Forsayeth; Krystof Bankiewicz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 664 KB

Adjunctive safinamide for symptoms of Pa

Adjunctive safinamide for symptoms of Parkinson's disease

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Safinamide in the treatment of Parkinson

Safinamide in the treatment of Parkinson's disease

✍ Schapira, Anthony HV 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 238 KB

Current Status of Symptomatic Medical Th

Current Status of Symptomatic Medical Therapy in Parkinson’s Disease

✍ Stewart A. Factor 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 153 KB

Symptomatic medical therapies for Parkinson's disease (PD) have been disease modifying and have led to improvement in daily function, quality of life, and survival. For 40 years, these therapies have been primarily dopaminergic, and currently include the dopamine (DA) precursor levodopa (LD), DA ago

Limitations of current Parkinson's disea

Limitations of current Parkinson's disease therapy

✍ Olivier Rascol; Pierre Payoux; Fabienne Ory; Joaquim J. Ferreira; Christine Bref 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Current status of Parkinson's disease tr

Current status of Parkinson's disease treatment in Korea

✍ Jin-Soo Kim; Young H Sohn 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 413 KB